Varicose Vein Treatment Market Set to Witness an Uptick by 2024|Top Industry Leaders Medtronic plc, Dornier MedTech GmbH

The Report Varicose Vein Treatment Market Analysis By Treatment Mode (Sclerotherapy, Endovenous Ablation (Laser Ablation, Radiofrequency Ablation), Stripping, And Segment Forecasts To 2024

The global varicose vein treatment market is expected to reach USD 475 million by 2024, according to a new report by Grand View Research, Inc. The increasing technological advancements coupled with the increased availability of the advanced varicose vein treatment devices and shift towards less-invasive procedures are the contributing factors for the growth of the market. 

The huge burden of vascular diseases in Europe and North America and the increasing patient compliance and reliability, growth in healthcare expenditure, and the rapid growth in geriatric population is majorly driving the varicose vein procedure market. 

The upward trend in lifestyle disorders, such as increasing obesity, sleep disorders, blood pressure levels, hormonal changes, genetic disorders and pregnancy are the few major factors contributing to the peripheral vascular diseases. Untreated venous insufficiency, such as varicose vein and venous ulcers cause progressive syndromes including chronic veinous insufficiency. In 2015, according to FutSci, chronic veinous insufficiency is widespread and is a socially isolating condition caused in adults. It is the most common disease in the world and is estimated to affect 5% of the population in the Western countries.  

Access Research Report of Varicose Vein Treatment Market @ www.grandviewresearch.com/industry-analysis/varicose-vein-treatment-devices-market

Further key findings from the report suggest: 

• In 2015, the sclerotherapy segment was identified as the most profitable procedure owing to the benefits, such as the requirement of minimal incision and reduced scarring, related to the procedure. Moreover,the following advantages: increased penetration, cost and time efficiency, reduced risk of collateral damage to surrounding tissues, fewer post-operative complications, and painless procedure are the main contributors for the growth of this segment.
• The endovenous ablation segment is expected to be the fastest growing segment due to the benefits of short treatment time and improved blood circulation after the procedure. The ClosureFast technique in the endovenous ablation treatment segmenthas gained momentum due to the minimized side effects, potential cost-saving ability, and better patient outcomes.
• In 2015, the endovenous chemoablation or chemical sclerosis segment was the most widely used medical procedure among the ablation procedures. Sclerotherapy, intense-pulsed-light therapy, laser ablation, radiofrequency, and ambulatory phlebectomy are the modern techniques that are usedmore oftendue to their less invasive nature.
• In 2016, North America held the largest market share due to the increasing incidence rate of varicose and spider vein in the population, favourable reimbursement policies, increased healthcare awareness, government spending, and the rising aesthetic awareness in the region
• As of 2016, Europe is characterized by a shift towards less-invasive procedures in treating large varicose veins. It is expected to witness a high growth rate over the forecast period due to the favorable government initiatives and advanced treatment procedures.
• The Asia Pacific is expected to register the fastest growth due to factors, such as the improving healthcare infrastructure, the increase in patient awareness level regarding the benefits of early treatment of the varicose veins, and the rising disposable income
• Some key players of the market include Quanta Systems S.p.A, Vascular Solutions, Inc., Eufoton S.R.L, Energist Group, Medtronic plc, Dornier MedTech GmbH, Lumenis Ltd., Syneron Medical Ltd., Biolitec AG, and AngioDynamics, Inc.
• AngioDynamics, Inc. and MerzPharma GmbH & Co. KGaAin North America established a multi-year relationship to market Asclera for patients with peripheral vascular diseases.In the U.S,.MerzPharma GmbH & Co. KGaAserves as the exclusive distributor of the Asclera Injection. Asclera is approved for the treatment of spider and reticular veins, which showed good improvement in 95% of the patients treated with asclera.
• In 2016, Medtronic plc acquired Italian hemodialysis player Bellco, Inc.This acquisition is projected to enable the medical device giant to gain market position in newly formed renal care solution business.
• In 2015, Medtronic plc acquired Covidien plc with the objective to move into the additional therapeutic areas, such as chronic venous insufficiency. Covidien plc markets the Venefit procedure that uses radiofrequency energy and minimally invasive radiofrequency ablation to treat the disease. 

Grand View Research has segmented the global varicose vein treatment market on the basis of procedures, devices,and regions: 

Varicose Vein Treatment Outlook ByType (Revenue, USD Million, 2013 - 2024)

• Sclerotherapy
• Endovenous Ablation
• Stripping

Varicose Vein Treatment Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dental Compressors Market Predicted to Cross USD 315.88 Million by 2020

Global Dental Compressors Market is expected to reach USD 315.88 Million by 2020, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of dental disorders is expected to drive market growth during the forecast period. Introduction of new products based on oil free technology such as AirStar 12 and AirStar 40 which are maintenance free and provide ultra-dry and clean air are also expected to serve the dental compressors market as drivers. Furthermore, commercialization of membrane based compressors is expected to boost usage rates. Key advantages associated with these compressors include low installation and operating costs, no moving parts and their ability to function in hazardous atmospheres. Moreover, membrane based dryers not only supply hygienic, dry and oil free air but also minimize infection risks and increase treatment efficiency by reducing maintenance levels.

Desiccant based dental compressors were the leading product segment in 2013 owing to its characteristic of not reacting chemically with moisture. In most of the European countries, desiccant compressors are more reliable as the weather in the region can get as high as 30 degree Celsius or as low as 0 degree Celsius. The fact that these compressors exhibit optimum performance at these temperature ranges is expected to drive market growth. Desiccant based compressors are expected to grow at a CAGR over 3.0% during the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/dental-compressors-market

Further key findings from the study suggest:

• The oil free compressors market is expected to grow at a CAGR of over 6.0% from 2014 to 2020. Key factors attributing to its fast growth includes their compact size and design enabling them to run smoothly with limited vibration and their ability to provide moisture oil and bacteria free dental air with very low maintenance cost.
• Dental compressors in handpieces accounted for over half of the market owing to rising prevalence of dental disorders, growing number of trained dental professional, rising patient awareness levels and increasing healthcare expenditure levels are few factors attributing to the growth of the dental care industry and the consequent rise in demand for dental compressors in handpieces.
• North America dominated the overall market in terms of market share in 2013 majorly on account of the presence of favorable reimbursement policies, economic development and increasing prevalence of dental disorders.
• The Asia Pacific dental compressors market is expected to grow at the fastest rate during the forecast period. Increasing geriatric population base, rising patient awareness levels and growing prevalence of target diseases are few factors attributing to its rapid growth.
• Key players operating in dental compressors include Midmark, Dürr Dental, Gnatus, Metasys, Tech West Inc, Kaeser Dental, Air Techniques, Aixin Medical Equipment Co., Ltd, Foshan Core Deep Medical Apparatus Co. Ltd, Best Dent Equipment Co., Limited, Slovadent, Dental EZ Group, Diplomat Dental Solutions and Fedesa.

For the purpose of this study, Grand View Research has segmented the global dental compressors market on the basis of product, technology, application and region:

Global Dental Compressors Product Outlook (Revenue, USD Million, 2012 – 2020)

• Dental lubricated compressors
• Dental oil-free compressors

Global Dental Compressors Technology Outlook (Revenue, USD Million, 2012 – 2020)

• Desiccant based compressors
• Membrane based compressors

Global Dental Compressors Application Outlook (Revenue, USD Million, 2012 – 2020)

• Handpieces
• Scalers
• Chair Valves

Dental compressors Regional Outlook (Revenue, USD Million, 2012 – 2020)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• MEA
  • Israel
  • South Africa
• Latin America
  • Brazil 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Surgical Imaging Market Booming Trends and Forecast Assessment for the Period 2019 to 2026

The global surgical imaging market size is projected to reach USD 7.3 billion by 2026 expanding at a CAGR of 5.2%, according to a new report by Grand View Research, Inc. Technological advancements and growing demand for minimally invasive surgeries are the key factors augmenting the market growth. Surgical imaging can be used with different modalities, such as optical mode, ultrasound, radiography, and nuclear medicine. Rising scope of applications of imaging modules in a wide range of surgery procedures is expected to create significant opportunities.

Demand for surgical imaging systems is expected to show a steep growth due to high prevalence of chronic diseases including cancer and lifestyle disorders, and rising geriatric population, and demand for non-invasive and minimally invasive surgical methods. The endoscopy and laparoscopy devices are extensively used in minimally invasive surgeries. Key companies in the global market use different strategies to sustain the competition. For instance, in June 2017, Philips acquired Electrical Geodesics, Inc. to launch a portfolio with integrated neurological imaging, therapy, and mapping guidance.

Access Research Report of Surgical Imaging Market @ https://www.grandviewresearch.com/industry-analysis/surgical-imaging-market

Further key findings from the study suggest:

• The X-ray segment is expected to lead the market on account of increasing prevalence of chronic diseases and demand for surgical imaging procedures for better treatment
• The demand for mobile X-ray devices is expected to grow rapidly owing to rising geriatric population and need for bedside imaging
• Orthopedic and trauma is anticipated to be the largest and fastest-growing application segment over the forecast years
• C-arms is expected to be the fastest-growing device segment in the global surgical imaging market
• North America accounted for the largest share with U.S. capturing the largest share of the regional market in 2017
• Some of the key companies include Siemens Healthcare; Hitachi Ltd.; GE Healthcare; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Hologic, Inc.; Medtronic, PLC; and Shimadzu Corporation

Grand View Research has segmented the global surgical imaging market on the basis of device, modality, application, and region:

Surgical Imaging Device Outlook (Revenue, USD Million, 2014 - 2026)

• Endoscopy
• Laparoscopy
• Angiography
• C-arms
• Surgical Navigation Systems

Surgical Imaging Modality Outlook (Revenue, USD Million, 2014 - 2026)

• MRI
• X-ray
• Computed Tomography
• Optical
• Nuclear Imaging
• Ultrasound

Surgical Imaging Application Outlook (Revenue, USD Million, 2014 - 2026)

• Neurosurgeries
• Cardiovascular
• Orthopedic and Trauma
• Gynecological
• Ophthalmological
• Thoracic
• Urologic
• Other

Surgical Imaging Regional Outlook (Revenue, USD Million, 2014 - 2026)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Disposables Market Analysis By Leading Players, Types, Growth Factors, Demand, Opportunities

The global medical disposables market is expected to reach USD 329.9 billion by 2024, according to the study performed by Grand View Research, Inc. Key factors driving the market expansion include the growing awareness regarding benefits of infection control, which majorly include enhanced quality of life and minimized related healthcare expenditure.

In addition, propelling factors of this sector comprise constantly rising hospital visits, surgeries, and the growing need for healthcare assistance owing to the escalating geriatric population prone to developing chronic diseases and injuries. Furthermore, the emergence of this sector is attributed to the increased focus toward the use of single-use disposable products to prevent cross-contamination and infection in healthcare settings.

These products offer a range of advantages to the healthcare institutions such as reducing sterilization and disinfection costs. Thus, most of the healthcare professionals and individual patients are turning toward disposable medical supplies to meet the infection control requirements.

Drug delivery products captured the largest revenue share in 2015. The segment is also expected to foresee the fastest growth rate due to the increasing use of prefilled syringes, needles, and transdermal patches by various hospitals and clinics.

The plastic resin segment accounted for the largest share in 2015 due to their wide availability and application in the healthcare sector. However, nonwoven material is forecasted to grow at the fastest CAGR owing to factors such as their low weight, affordable cost, and easy recycling methods. Nonwoven fabric is the material of choice for a number of applications such as wound care management, incontinence management, and surgeries due to the highly absorbent and liquid repellent nature of this material, among other properties.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-disposables-market

Further Key Findings from the Study Suggest:

• In 2015, the drug delivery product segment captured the largest revenue share. The increasing application of various drug delivery products for sustained-release drug therapies is mainly contributing to the largest share of the segment globally.
• In addition, rising demand for minimally invasive surgeries is spurring the demand for needles and drug delivery devices, which is resulting in the high revenue generation of the segment
• With the introduction of advanced technology and growing demand for accurate diagnostic methods, the diagnostic and laboratory disposables segment is expected to show the second fastest growth during the forecast period
• North America region dominated the overall market by capturing over 35.0% share in 2015. This region is anticipated to remain dominant throughout the forecast period.
• Some of the factors having a significant impact on the regional market growth are government initiatives, high per capita income, large patient pool, and the presence of a large number of major players in the region
• Growing economies and government-led initiatives are expected to drive the growth of the medical disposables sector in the Asia Pacific region. The segment is expected to witness a lucrative CAGR of over 7% during the forecast period.
• Some of the major players in the consolidated market are 3M, Johnson & Johnson Services, Inc., Abbott, Becton, Dickinson & Company, Medtronic, B. Braun Melsungen AG, Bayer AG, Smith and Nephew, Medline Industries, Inc., and Cardinal Health

Grand View Research has segmented the medical disposables market by product, raw material, end use, and region:

Type Outlook (Market revenue in USD Million, 2014 - 2024)

• Wound Management Products
• Drug Delivery Products
• Diagnostic and Laboratory Disposables
• Dialysis Disposables
• Incontinence Products
• Respiratory Supplies
• Sterilization Supplies
• Nonwoven Disposables
• Others

Raw Material Outlook (Market revenue in USD Million, 2014 - 2024)

• Plastic Resins
• Nonwoven Material
• Rubber
• Paper and Paperboard
• Metals
• Glass
• Others

End Use Outlook (Market revenue in USD Million, 2014 - 2024)

• Hospitals
• Home Healthcare
• Outpatient/Primary care Facilities
• Others

Regional Outlook (Market Revenue in USD Million, 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pyrogen Testing Market Poised to Expand at a Robust Pace Over 2025

The global pyrogen testing market is expected to reach a value of USD 1.9 billion by 2025, according to a new report by Grand View Research, Inc. Increasing demand for therapeutic drugs including pharmaceuticals, biopharmaceuticals, and biologics is the major factor that propels growth of the market during forecast period. Pyrogen is a toxic molecular substance that causes fever if induced in animal or human body. Pyrogen testing is used by pharmaceutical, biopharmaceuticals, biotechnology, and medical devices companies to confirm the absence of pyrogen. Thus, the companies use various methods such as LAL, in vitro pyrogen, and rabbit test to ensure the quality of products.

Increasing prevalence of chronic diseases, is another foremost factor supporting the growth of the pyrogen testing market. The prevalence of chronic diseases is very high in developed countries and is growing at high pace in developing countries including China and India. Different factors such as unhealthy diet, smoking, alcohol consumption, and lack of exercise leads to occurrence of chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases.  Hence, there is a growing demand for therapeutic drugs and medical devices for the treatment of such diseases, which in turn is projected to fuel the demand for pyrogen testing to ensure the quality of products including drugs and devices.

Access Research Report of Pyrogen Testing Market @ https://www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further key findings from the study suggest:

• Consumables was the largest revenue grossing segment of the pyrogen testing market in 2016, owing to the large application of pyrogen testing kits and reagents along with its repetitive purchase
• Instruments segment accounted for the remarkable share in the market in 2016 and is also expected to showcase significant growth during forecast period, owing to rising demand for pharmaceutical, biologics, and medical devices for treatment and diagnosis
• The pharmaceutical and biotechnology companies segment dominated the pyrogen testing market in terms of revenue in 2016, due to the large production of therapeutic drugs and growing investment in R&D by companies for drug development
• North America is the leading regional market and accounted for the largest revenue share in 2016 primarily due to the existence of large number of healthcare companies including pharmaceuticals and medical devices in this region
• The Asia Pacific region is anticipated to be the fastest growing market during the study period. The growing prevalence rate of chronic diseases in the Asian countries including India and China, is a major factor contributing to the expansion of market in this region.
• Some major players serving this vertical include Charles River Laboratories, Inc.; Ellab A/S; Merck KGaA; GenScript; Hyglos GmbH; Lonza; Thermo Fisher Scientific, Inc.; Associates of Cape Cod, Inc.; and Pyrostar

Grand View Research has segmented the pyrogen testing market on the basis of product, test type, end-use, and region:

Pyrogen Testing Product Outlook (Revenue, USD Million; 2014 - 2025)

• Consumables
• Instruments
• Services

Pyrogen Testing Test Type Outlook (Revenue, USD Million; 2014 - 2025)

• LAL test
• Chromogenic test
• Turbidimetric test
• Gel clot test
• In vitro pyrogen test         
• Rabbit test

Pyrogen Testing End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Pharmaceutical and biotechnology companies
• Medical devices companies
• Others

Pyrogen Testing Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Hyperbaric Oxygen Therapy Devices Market to Expand At A CAGR Of 6.5% through 2025|Key participants IHC Hytech B.V.

The Report Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market Analysis By Product (Monoplace, Multiplace, Topical HBOT Devices), By Application (Wound Healing, Infection Treatment, Gas Embolism), And Segment Forecasts, 2018 - 2025

The global hyperbaric oxygen therapy devices market is expected to reach USD 3.91 billion by 2025, according to a new report by Grand View Research, Inc. Growing inclination of healthcare professionals toward oxygen therapy, despite a lack of conclusive evidence is one of the key factors expected to drive the market over the coming few years.

Although the off-label usage of HBOT devices in various applications such as cancer and brain injury is controversial, the adoption rate of this technology is surging at a rapid pace. The high commercial availability of HBOT systems is one of the crucial factors that is anticipated to drive the market over the forecast period. However, few medical professionals are still skeptical about the usage of HBOT devices in unapproved applications, which is expected to impede growth. The technological advancements in this field such as portable HBOT system and growing awareness among healthcare professionals regarding the benefits of integrating ICU systems in multiplace HBOT equipment are some of the key contributors that are accountable for robust growth rate.

According to few publications, nearly 30,000 HBOT treatments are done on a daily basis globally. Other than the surging clinical prevalence and rising adoption of hospital setting HBOT systems, there is a considerable growth in popularity and demand for HBOT systems in home settings owing to its easy usage. Increasing private & public investment to expand geographical presence and surging R&D activities are also some of the factors that are anticipated to boost the demand.

Access Research Report of Hyperbaric Oxygen Therapy Devices Market @ www.grandviewresearch.com/industry-analysis/hyperbaric-oxygen-therapy-market

Further Key Findings From the Report Suggest:

• The global hyperbaric oxygen therapy (HBOT) market size was estimated at USD 2,210.5 million in 2016 and is expected to grow at a CAGR of 6.5% from 2017 to 2025
• Monoplace HBOT Devices segment emerged as the largest product segment in 2016 and is estimated to generate revenue over USD 3,008.8 million by 2025
• Other applications such as acute carbon monoxide poisoning, chemotherapy-induced hemorrhagic cystitis, and cyanide poisoning generated revenue of USD 229.1 million in 2016 and is anticipated to witness fastest growth over the next 8 years
• The Asia Pacific region is anticipated to witness lucrative growth over the next decade owing to various developments in healthcare infrastructure and technological advancements in the medical device industry across major emerging economies. It is expected to grow at a CAGR of 7.1% over the forecast period.
• Some of the key players including Fink Engineering; HAUX-LIFE-SUPPORT; ETC Hyperbaric Chambers (Environmental Tectonics Corporation); Gulf Coast Hyperbarics, Inc.; IHC Hytech B.V. (Royal IHC); HEARMEC; Hyperbaric; Sechrist Industries, Inc.; OxyHeal International; and SOS Group Global Ltd. dominated the global hyperbaric oxygen therapy devices market.

Grand View Research has segmented the global hyperbaric oxygen therapy (HBOT) devices market on the basis of product, application, and region:

HBOT Devices Product Outlook (Revenue, USD Million, 2014 - 2025)

• Monoplace HBOT Devices
• Multiplace HBOT Devices
• Topical HBOT Devices

HBOT Devices Application Outlook (Revenue, USD Million, 2014 - 2025)

• Wound Healing
• Decompression Sickness
• Infection Treatment
• Gas Embolism
• Others

HBOT Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

ePharmacy Market Expected To Expand At A CAGR Of 14.8% From 2018 To 2025

The global ePharmacy market is expected to reach USD 109.2 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by constant increase in the number of internet users, improved access to web-based & online services, and rapid increase in aging population who find it difficult to visit pharmacies. Convenience, affordability, and ease in availability of medicines are fueling market growth.

Increase in prevalence of chronic conditions and diseases across the globe is resulting in constant growth in demand for various drugs and healthcare products. High cost of treatment is indicating the need to reduce health care cost. Online pharmacies are gaining popularity owing to lucrative offers such as price discounts that result in cost savings. In addition, increase in adoption of e-prescriptions in hospitals and other healthcare facilities is further expected to boost growth.

High unmet needs of emerging economies is one of the key driving factors. Government initiatives, increase in investments, changing regulations, and increasing penetration of internet and broadband in urban as well as rural areas are contributing to the growth of the market. Many new players are entering the market as the healthcare sector is offering huge potential to the online health retailers due to the ever growing demand for healthcare products and services.

However, growth in illegal online pharmacies is restraining the growth. These illegitimate websites may offer counterfeit and unapproved drugs, which make people skeptical about purchasing medicines online.

Access Research Report of ePharmacy Market @ https://www.grandviewresearch.com/industry-analysis/epharmacies-market

Further Key Findings From the Report Suggest:

• North America held majority of the share in 2016 due to increase in online purchases, growing elderly population, and high adoption of IT in healthcare
• The U.S. is the largest market in North America owing to the presence of various key players and a large tech-savvy population
• Asia Pacific is expected to be the fastest growing segment due to the presence of emerging economies like China & India and improving infrastructure
• Some of the key players are The Kroger Co., Walgreen Co.; Wal-Mart Stores, Inc.; CVS Health; Express Scripts Holding Company; Giant Eagle, Inc.; DocMorris (Zur Rose Group); Rowlands Pharmacy; and OptumRx, Inc.

Grand View Research has segmented the ePharmacy market on the basis of region:

e-Pharma Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Soft Tissue Repair Market To Reap Over USD 10.73 Billion In Revenues By End Of 2025

The global soft tissue repair market size is expected to reach USD 10.73 billion by 2025, expanding at a CAGR of 7.3%, according to a new report by Grand View Research, Inc. Growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years.

Soft tissue comprises of muscles, ligaments, tendons, fibrous tissue, skin, synovial membranes, nerves and others which protect organs, enable movement and support bones in the body. Injury to the soft tissues can cause severe pain and also may stop movement of the bones, which if left untreated can lead to chronic pain. Over the long-term, injuries hamper everyday life of the patients as it becomes difficult to work, socialize or even move. Most of the injuries are caused because of sprain, trauma of strain on the muscles. Soft tissue repair surgery comprises of procedures wherein devices like grafts, sutures, anchors and other devices are used to remodel, reshape or fix the damaged parts to restore its functionality. With the growing number of related injuries, the products used in repair surgeries are expected to witness exponential demand over the forecast period.

Factors influencing soft tissue repair market growth are growing number of patients suffering from sports related injuries. Sprains, contusions, strains, tendinitis, and bursitis are some common injuries, that are suffered by athletes. Growing awareness about impact of these injuries on athletes’ performance and awareness regarding available treatment options for soft tissue repair are expected to promote revenue growth of the market. Ageing population is another significant factor promoting revenue growth. Old people are more susceptible to fractures and trauma associated injury and often require joint replacement and reconstruction surgeries. According to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/soft-tissue-repair-market

Further Key Findings From the Report Suggest:

• The global soft tissue repair market size was estimated at USD 5.73 billion in 2016 and is expected to grow at a CAGR of 7.3% from 2017 to 2025
• Fixation products emerged as the largest product type segment in 2016 and is estimated to generate revenue over USD 6.15 billion by 2025
• Orthopedic surgery segment was estimated at USD 1.47 billion in 2016 and is anticipated to witness fastest growth over the forecast period
• The Asia Pacific region is projected to witness substantial growth over the next decade owing to various developments across major economies in the region. This regional market is expected to grow at a CAGR of 7.7% from 2017 to 2025
• Some of the key players including Stryker Corporation; Arthrex, Inc.; C.R.Bard, Inc., Integra LifeScience Corporation, Smith & Nephew plc. and Depuy Synthes

Grand View Research has segmented the global soft tissue repair market on the basis of product, application and region:

Soft Tissue Repair Product Outlook (Revenue, USD Million, 2014 - 2025)

• Fixation Products
  • Suture
  • Suture Anchors
• Tissue Patch/Match
  • Biological
  • Synthetic

Soft Tissue Repair Application Outlook (Revenue, USD Million, 2014 - 2025)

• Orthopedic Surgery
• Breast Reconstruction
• Hernia Repair
• Skin Repair
• Vaginal Sling Repair
• Cardiovascular Surgery
• Dental Reconstruction
• Others

Soft Tissue Repair Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pruritus Therapeutics Market to Record an Exponential CAGR by 2025

Global pruritus therapeutics market is expected to reach USD 16.38 Billion by 2025, according to a new study by Grand View Research, Inc. Growing worldwide prevalence of atopic dermatitis, allergic contact dermatitis and urticaria is expected to drive market growth during the forecast period. Introduction of new products based on scientific mechanistic understanding such as the identification of new T-cell subsets, particularly Th17, and Th22 and the patent expiration of PROTOPIC (tacrolimus) is expected to open up new avenues for manufacturers to capitalize on over the forecast period. 

Corticosteroids were the leading product segment in 2013 owing to high efficacy exhibited by this class of drugs in treating pruritic conditions by reducing inflammation and itching. Topical applications of corticosteroids have been found to be extremely effective in the treatment and maintenance therapies pertaining to pruritus.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/pruritus-therapeutics-market

Further key findings from the study suggest:

• Calcineurin inhibitor is identified as the most lucrative segment of the market on account of high usage rate of these drugs in combination therapy for the treatment of pruritus in patients suffering from chronic pruritus and growing market penetration rates. Moreover, the introduction of new products such as Pimecrolimus cream and Tacrolimus ointment is expected to further drive this market.
• Anti-histamines owing to its growing use as a first line treatment and presence of drugs in pipeline with expected commercialization is also expected to grow at a healthy rate during the forecast period.
• North America led the overall market in terms of revenue in 2013 majorly on account of the presence of high prevalence of diseases associated with pruritus, introduction of new products targeting the unmet medical needs and growing patient awareness levels.
• The Asia Pacific pruritus therapeutics market is expected to grow at a CAGR of over 5.0% during the forecast period. Presence of high unmet healthcare needs and increasing prevalence of allergic contact dermatitis and urticaria in this region are some factors attributing to its rapid growth rate.
• Some key participants of the pruritus therapeutics market include Sanofi, Pfizer, Tai Guk Pharmaceutical Company, Actavis, Trevi Therapeutics, Cara Therapeutics, Ocera Therapeutics Inc. and NeRRe Therapeutics.
• Manufacturers adhere to rigorous R&D in an attempt to develop cost effective products and avoid barriers such as product recalls. In addition, this strategy is implemented keeping the unmet needs in consideration. For Instance, Creabilis has a molecule in the pipeline – CT327, which caters to the unmet needs associated with pruritus in patients suffering from psoriasis. 

Grand View Research has segmented the global pruritus therapeutics market on the basis of product, disease type and region:

Global Pruritus Therapeutics Product Outlook (Revenue, USD Million, 2012 - 2025)

• Corticosteroids
• Antihistamines
• Local Anesthetics
• Counterirritants
• Immunosuppressant
• Calcineurin Inhibitors
• Others

Global Pruritus Therapeutics Disease Type Outlook (Revenue, USD Million, 2012 - 2025)

• Atopic Dermatitis
• Allergic Contact Dermatitis
• Urticaria
• Others

Global Pruritus Therapeutics Regional Outlook (Revenue, USD Million, 2012 - 2025)

• North America
  • US.
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • Rest of Asia Pacific
• RoW 

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Human Growth Hormone Market to Expand At A CAGR Of 8.2% from 2020 to 2027

The global human growth hormone market size is expected to reach a value of USD 8.5 billion by 2027, registering a CAGR of 8.2% over the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel therapies, increasing R&D activities, and rising awareness for the diagnosis and treatment of growth hormone (GH) disorders are expected to drive the market over the forecast period.

Key players operating in the market are involved in extensive R&D activities for the development of novel GH therapies to strengthen their position in the market. For instance, in October 2019, VISEN Pharmaceuticals, a joint venture of Denmark-based Ascendis Pharma A/S, received approval from China National Drug Administration (NMPA) for its new drug (IND) application to start Phase III clinical study of TransCon hGH. Furthermore, two South Korean companies, Genexine Inc. and Handok Inc., are conducting a Phase II clinical trial study on GX-H9, a recombinant human GH for the treatment of adult and pediatric GH deficiency.

Furthermore, increase in the number of regulatory approvals and launch of novel hGH therapies are expected to fuel the market over the forecast period. For instance, in January 2018, Ferring Pharmaceuticals Inc., a Switzerland-based pharmaceutical company, received United States Food and Drug Administration (USFDA) approval for its new recombinant hGH, Zomacton (somatropin) indicated for the treatment of adult patients with GH deficiency.

Various government and private organizations have been undertaking initiatives and programs to spread awareness about GH deficiency and facilitate timely diagnosis and treatment. Nonprofit organizations such as Human Growth Foundation are engaged in providing research support and spreading awareness about GH deficiency and its treatment. Such initiatives are expected to drive the demand for hGH treatment therapies.

Access Research Report of Human Growth Hormone Market @ https://www.grandviewresearch.com/industry-analysis/human-growth-hormone-drugs-market

Further key findings from the study suggest:

• GH deficiency was the largest application segment in 2019 owing to increase in regulatory approvals and launch of novel therapies
• Rising awareness about GH deficiency, coupled with increasing hospital visits for its treatment, is expected to drive the hospital distribution channel segment
• North America dominated the human growth hormone market with the largest share in 2019. This is attributed to favorable reimbursement scenario, high awareness, and the presence of major players in the region
• Asia Pacific is projected to witness a lucrative CAGR over the forecast period owing to increasing penetration of key players with their new growth hormone therapies
• The key players include Novo Nordisk A/S; Pfizer Inc.; Eli Lilly and Company; Sandoz International GmbH (Novartis AG); Merck KGaA; Genentech, Inc. (Roche); Ferring Pharmaceuticals; Teva Pharmaceutical Industries, Ltd; and Ipsen.

Grand View Research has segmented the global human growth hormone market on the basis of application, distribution channel, and region:

Human Growth Hormone (hGH) Application Outlook (Revenue, USD Million, 2016 - 2027)

• Growth Hormone (GH) Deficiency
  • Adult GH Deficiency
  • Pediatric GH Deficiency
• Turner Syndrome
• Idiopathic Short Stature
• Prader-Willi Syndrome
• Small for Gestational Age
• Other

Human Growth Hormone (hGH) Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Specialty Pharmacy

Human Growth Hormone (hGH) Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Ophthalmic Devices Market is Expected to Grow at the Fastest CAGR at over 6.0% by 2024| Key participants Johnson & Johnson, Essilor International S.A

The global ophthalmic devices market is expected to reach USD 55.5 billion by 2024, according to a new report by Grand View Research, Inc. The rising geriatric population base is presumed to propel the need for ophthalmic devices as this age group is more prone towards the development of chronic eye disorders. The rising prevalence of eye disorders such as macular degeneration, cataract, diabetic retinopathy and glaucoma is also boosting the growth of ophthalmic devices.

Approximately 10% of the people suffering from eye disorders will experience loss of vision in spite of the proper treatment as per the statistics of the WHO, driving the clinical urgency to incorporate highly advanced ophthalmic devices. Additionally, the rising demand for minimally invasive and complication-free operative surgeries is expected to upsurge the demand for ophthalmic devices.

The ophthalmic devices market growth can also be attributed to technological advancements such as the development of intraocular lenses, mydriatic fundus cameras, and OCT devices. Furthermore, the increasing involvement of market players in expanding treatment solutions through strategic alliances is expected to present this market with a potential growth platform. For instance, in May 2016, Bausch & Lomb through its enterprise partnership with Apple and IBM will develop a cataract surgery app that would integrate patient data, calculation data, and records thereby helping cataract surgeons’ work efficiently. The app will be enabled with IBM’s cognitive computing capabilities to reduce surgical errors.

Access Research Report of Ophthalmic Devices Market @ https://www.grandviewresearch.com/industry-analysis/ophthalmic-devices-market

Further key findings from the study suggest:

• The vision care segment dominated the product segment of the overall ophthalmic devices market in terms of revenue share at over 78.0%in 2015,owing to its adoption in vision correction procedures and the rising number of initiatives to promote the awareness pertaining to vision care
• For instance, in April 2016, Alcon announced its support to the “Think About Your Eyes”, which is a public awareness program. Alcon committed USD 4 million to support this initiative to promote the awareness pertaining to vision care
• The diagnostic& monitoring devices segment is expected to grow at the fastest CAGR at over 7.0% in 2015. This can be attributed to the fact that diagnosis is an indispensable process in the treatment of eye disorders and is responsible for contributing towards the diagnostics & monitoring segment’s growth
• In 2015, North America dominated the overall ophthalmic devices market at over 36.0%owing to the increasing utilization of ophthalmic devices in hospitals and private clinics. Moreover, subsequent changes in demographic trends, such as a rise in the geriatric population & unhealthy lifestyles, are presumed to drive the market in this region. Moreover, high R&D investments in the development of new products are expected to impel the market growth in North America
• Asia Pacific is anticipated to be growing at the fastest CAGR of around 7.0% over the forecast period due to the presence of untapped opportunities in the emerging economies in China and India. Moreover, the increasing government initiatives towards healthcare infrastructure; for instance, in China, healthcare reforms through an initiative called New Health Care Reform Plan implemented by the Chinese State Council and the Communist Party of China (CPC) Central Committee is expected to drive growth of the Chinese regional market.
• Some key players in this market are involved in adopting collaborative strategies and indulge in frequent product approvals to facilitate business and geographical expansions. For instance, in February 2016, Alcon acquired Transcend Medical, Inc., in a probe to expand its business in the treatment of glaucoma. This acquisition added Minimally Invasive Glaucoma Surgical (MIGS) devices to Alcon’s product portfolio.

Grand View Research has segmented the ophthalmic devices market on the basis of product and region:

Global ophthalmic devices product outlook (Revenue, USD Million, 2013 - 2024)

• Diagnostics & Monitoring Devices
• Surgical Instruments
• Vision Care Products

Ophthalmic devices regional outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Personal Mobility Devices Market Poised to Garner Maximum Revenues During 2020 – 2027

The global personal mobility devices market size is expected to reach USD 17.9 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.5% over the forecast period. Growing R&D investments for new product development and government initiatives aimed at strengthening reimbursement frameworks are some of the key factors propelling market growth.

Surge in geriatric population and prevalence of target diseases such as arthritis, Parkinson’s, and Alzheimer’s among the global population are some key factors expected to drive the personal mobility devices market market over the forecast period. According to WHO in 2019, the number of people aged 60 and above is likely to grow by 56.0% from 962 million in 2017 to 1.4 billion in 2030.

Rising number of surgical procedures due to rising prevalence of neurological and cardiovascular disorders and increasing number of accidents and trauma cases are expected to drive the market for personal mobility devices over the forecast period. According to WHO the number of surgeries grew by about 40.0% from 2004 to 2012.

Europe was the most mature market for personal mobility devices in 2019. It generated the maximum revenue that year, accounting for 33.0% of the global market. Sophisticated healthcare infrastructure and growing healthcare expenditure are some of the factors contributing to its dominant share. Asia Pacific is expected to grow at a lucrative pace during the forecast period. This region is expected to witness a rapid gain in demand for personal mobility devices over the coming years owing to growing geriatric population, increasing disposable income and greater spending on healthcare, and rising awareness levels about the availability of various kinds of personal mobility devices.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/personal-mobility-devices-market

Further key findings from the report suggest:

• By product, wheelchair was the largest segment in 2019 owing to increase in demand for powered wheelchairs, especially in developed countries such as U.S. and Germany
• Premium rollators are identified as the most lucrative segment in this market owing to its ability to handle heavy weight, enhanced height, and handle adjustment mechanism
• Europe dominated the market in 2019 with a 33.0% share due to growing geriatric population and increase in healthcare expenditure in the region
• Asia Pacific is expected to grow at a rapid pace over the forecast period owing to growing geriatric population, increasing disposable income, and rising awareness levels
• Some of the players operating in the market are Drive DeVilbiss Healthcare; GF HEALTH PRODUCTS, INC.; Invacare Corporation; Carex Health Brands, Inc.; Kaye Products, Inc.; Briggs Healthcare; Medline Industries, Inc.; NOVA Medical Products; Performance Health; and Rollz International
• Development of advanced personal mobility devices via extensive R&D investments and entering into strategic alliances with buyers are some key sustainability strategies adopted by these market players.

Grand View Research has segmented the global personal mobility devices market based on product and region:

Personal Mobility Devices Product Outlook (Revenue, USD Million, 2016 - 2027)

• Wheelchairs
  • Manual
  • Power
• Scooters
• Walking Aids
  • Rollators
    • Low cost
    • Premium
  • Other Walking aids (canes, crutches, walkers)

Personal Mobility Devices Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • China
  • Japan
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antidiabetics Market Booming Trends and Forecast Assessment for the Period 2020

Global antidiabetics market is expected to reach USD 84.13 billion by 2020, according to a new study by Grand View Research, Inc. Growing prevalence of diabetes is the primary driver of this market. Growth in prevalence of disease causing lifestyle disorders such as irregular dietary habits and obesity is also expected to boost product demand by triggering incidence rates of target diseases. Future commercialization of products currently in the pipeline and the presence of large untapped opportunities in the emerging Asia Pacific and Latin American markets is expected to fuel future market growth.

Insulin was the most revenue generating segment and its market was valued at over USD 20.0 billion in 2013. Insulin is also one of the most lucrative segments of this market. Introduction of new products exhibiting higher efficacy coupled with the presence of favorable government initiatives are some factors attributing to its market attractiveness.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/antidiabetics-market

Further key findings from the study suggest:

• Long acting insulin was the leading product segment in 2013 and is expected to grow at the CAGR of over 15.0% during the forecast period. The introduction of advanced products, high prices associated with these products and the phasing out of human insulin are some key factors attributing for its large share.
• Rapid uptake of newly approved DPP-4 inhibitors such as Januvia, Nesina and Onglyza on account of their once daily dosage regimens and safety profiles catalyzed the growth of this market.
• North America was the most matured antidiabetics market in 2013 accounting for over 43.0% of the market High market penetration of insulin and other antidiabetics and the presence of sophisticated reimbursement framework are expected to drive regional market growth.
• Asia Pacific is expected to present manufacturers with lucrative future growth opportunities. Large presence of unmet patient needs and rapidly improving healthcare infrastructure are some factors expected to drive market growth in the region. The market is also expected to be driven by the introduction of cheaper products made available by local manufacturers.
• Some key market players of antidiabetics include Sanofi Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals Inc., Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics and Pfizer.
• The market is oligopolistic in nature with few players accounting for over 70% of the market. Extensive R&D investments aimed at new product development and entering new markets via government contracts are the key sustainability strategies adopted by these organizations.

Grand View Research has segmented the global antidiabetics market on the basis of product and region:

Global Insulin Product Outlook (Revenue, USD Million, 2012 - 2020)

• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting

Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 - 2020)

• Alpha-glucosidase inhibitors
• Biguanides
• Sulphonylureas
• GLP-1 agonist
• Meglitinides
• DPP-4 inhibitors
• SGLT - 2
• Thiazolodinediones

Antidiabetics Regional Outlook (Revenue, USD Million, 2012 - 2020)

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Electronics Market Size, Share, Trends, Analysis And Growth Forecast To 2024

The global medical electronics market size is expected to reach USD 219.0 billion by 2024, according to a new report by Grand View Research. Technological advancements have boosted the applications of electronics in the fields of diagnostics, therapeutics, and wellness. Increasing geriatric population coupled with sedentary lifestyle contributes to chronic cardiovascular, gastrointestinal, and respiratory disorders.

Diagnostic applications of medical electronics are fueled due to growing awareness about healthcare amongst people. Population in developed countries opts for early diagnosis for effective treatment and cure. Increasing adoption of newer technology in diagnostics is expected to upsurge the market in future. 

Aging population creates need for critical care of long duration, thus increasing the demand for life-supporting devices, such as ventilators and dialysis devices. Growing number of accidents and permanent injuries also contribute to this upsurge. Improving healthcare facilities eases the procedures of reimbursements and related medical procedures even in developing countries.

Industry players are focused on the commercialization of new technologies and integrated systems. In August 2016, Siemens launched a new product, Sysmex CS-2500. It is a coagulation analyzer and has applications in diagnostics. 

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-electronics-market

Further Key Findings from the Study Suggest:

• Rising prevalence of chronic diseases, such as neurodegenerative and cardiac diseases, creates a need for continuous patient monitoring. Constant development of technologies such as real-time audio/video feed, wireless communications, and remote patient monitoring proves to be a boon for chronic patients, especially those who prefer to receive treatment at home. All these factors are expected to act as a catalyst for the market growth over the forecast period.
• The largest application of medical electronics is in the field of diagnostics, especially imaging. Increasing importance of early disease diagnosis is promoting the growth of this segment. Magnetic resonance imaging is the most common method used, owing to the growing neurological and musculoskeletal disorders and the development of superconducting magnets.
• Ultrasound is projected to be the fastest-growing segment of medical imaging, owing to its applications in point-of-care and musculoskeletal diseases. Growing birth rate also contributes to the usage of ultrasound. Rising awareness coupled with government recommendations about periodic screening for cancer also contributes to this growth.
• Considering home healthcare medical electronics, device such as glucometer is used by diabetic patients owing to the ease of use of the device, and cost-effectiveness.
• The emphasis on preventive measure and early diagnosis rather than on treatment is driving the industry players to invest in remote, wireless, and minimally invasive equipment. This is predicted to set the trend of telehealth, self-monitoring, and home healthcare. In February 2016, Medtronic launched its first remote monitoring pacemaker in Canada. The data collected and interpreted is transmitted securely to the physician to make efficient treatment decisions.
• North America dominated the medical electronics market owing to the presence of well-structured healthcare and reimbursement systems. High prevalence of chronic lifestyle diseases, growing awareness about the importance of early diagnosis, and acceptance of new technology contributed to the market growth in this region.
• Asia pacific is expected to emerge as the fastest growing region during the forecast period. The huge patient pool in Asia Pacific proves to be an attractive opportunity for companies to market their products in this region. Improving healthcare systems, high incidence rate of diseases and accidents, and stabilizing economies aid the market growth.
• Some key participants include EDDA technology, Inc., Philips healthcare, FUJIFILM Medical Systems, Hitachi High Technologies Corporation, Toshiba Medical Systems Corporation, McKesson Corporation, Vucomp, Hologic Inc., Siemens Healthcare and iCAD, Inc.
• The current trend of investing in development of new technologies is expected to benefit patients as well as practitioners. For instance, in March 2016, Maxim Integrated launched its new heart rate monitor integrated with pulse oximeter. This device helps in continuous monitoring and efficient treatment of cardiovascular patients.

Grand View Research has segmented the global medical electronics market by application:

Medical Electronics Application Outlook (Market revenue in USD Million, 2013 - 2024)

• Imaging
  • MRI Equipment
  • Computed Tomography (CT)
  • Nuclear imaging equipment
  • X-ray Devices
  • Ultrasound Systems
• Therapeutics
  • Cardiac Rhythm Management (CRM)
  • Dialysis
  • Continuous Positive Airway Pressure (CPAP)
  • Neuromodulation
  • Others
• Patient monitoring
• Home Healthcare/Handheld products

Medical Electronics Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Enterprise Wearable Market Technological Advancement and Regional Outlook During 2018-2025

The global enterprise wearable market is expected to reach USD 22.3 billion by 2025, according to a new study conducted by Grand View Research, Inc. The high demand for enterprise wearable devices in the Asia Pacific region is anticipated to drive the industry growth over the next decade. The aging population and rising chronic diseases, such as coronary heart diseases and diabetes, in countries such as China, India, and Japan would drive the demand for wearable technology in the region.

Industry players are investing a significantly in research & development activities for product innovation, thus catering to the specific needs of the enterprise industry. They are using strategies such as acquisition, partnerships, and collaborations to maintain market competencies.

The rising enterprise applications of Virtual Reality (VR) and Augmented Reality (AR) in the following years is expected to fuel the demand for wearable devices, such as smart eye wear and head mounted devices.  This growth in demand may be attributed to advancements in the VR and AR technologies, which would help increase their connectivity and enterprises’ interaction with employees and consumers.

The increasing awareness regarding health and wellness, rising aging population, and chronic diseases such as heart attack and diabetes, globally, are favorable factors expected to support the demand for wearable devices over the forecast period.

The rising demand for IoT technology, owing to its wide application in various sectors such as healthcare, manufacturing, retail, and others, is foreseen to drive the growth of the enterprise wearable market. The IoT technology, along with wearable devices, would help organizations in the development and deployment of the future generation value-added services by utilizing user-centric data.

Access Research Report of Enterprise Wearable Market@ http://www.grandviewresearch.com/industry-analysis/the-global-enterprise-wearables-market

Further key findings from the study suggest:

• The IoT technology segment is expected to surpass the Bluetooth segment and dominate the market after 2022 as well. This growth may be attributed to the expected rise of widespread real-time applications of IoT technology in different industries globally over the next decade.
• The demand for head wear devices is expected to gain momentum over the forecast period owing to their prospective applications in highly developing technologies such as VR and AR
• The Asia Pacific region is predicted to emerge as the fastest growing market owing to a significant rise in the number of adopters of medical wearable devices for monitoring bodily conditions, such as glucose level, heart condition, temperature, sleep, and others, in countries such as China and India
• Prominent vendors operating in the market include Fitbit Inc., Apple Inc., Alphabet Inc., Xiaomi Inc., Samsung Electronics Co. Ltd., Eurotech SpA, Adidas AG, and Seiko Epson Corporation
• The increased focus on research and development activities for new product developments and upgrades of existing products to meet industry demands are the key trends adopted by industry player

Grand View Research has segmented the global enterprise wearable market on the basis of technology, product, application, and region:

Technology Outlook (Revenue, USD Million; 2014 - 2025)

• IoT
• Bluetooth
• Bluetooth Low Energy (BLE)

Product Outlook (Revenue, USD Million; 2014 - 2025)

• Wrist-wear
• Foot wear
• Eye wear
• Arm wear
• Head wear

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Infotainment
• Healthcare
• IT & telecom
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

 About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.